SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Floisand Yngvar)
 

Search: WFRF:(Floisand Yngvar) > Complement Componen...

  • Thomas, Anub M.Oslo Univ Hosp, Norway;Univ Oslo, Norway (author)

Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • 2019-09-15
  • American Association for Immunologists,2019
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:lnu-89311
  • https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-89311URI
  • https://doi.org/10.4049/jimmunol.1900047DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Heme is a critical danger molecule liberated from hemeproteins in various conditions, including from hemoglobin in hemolytic diseases. Heme may cause thromboinflammatory damage by activating inflammatory and hemostatic pathways, such as complement, the TLRs, coagulation, and platelets. In this study, we explored the effect of single and dual inhibition of complement component C5 and TLR coreceptor CD14 on heme-induced thromboinflammation in an ex vivo human whole blood model. Heme induced a dose-dependent activation of complement via the alternative pathway. Single inhibition of C5 by eculizumab attenuated the release of IL-6, IL-8, TNF, MCP-1, MIP-1 alpha, IFN-gamma, LTB-4, MMP-8 and -9, and IL-1Ra with more than 60% (p < 0.05 for all) reduced the upregulation of CD11b on granulocytes and monocytes by 59 and 40%, respectively (p < 0.05), and attenuated monocytic tissue factor expression by 33% (p < 0.001). Blocking CD14 attenuated IL-6 and TNF by more than 50% (p < 0.05). In contrast to single inhibition, combined C5 and CD14 was required for a significantly attenuated prothrombin cleavage (72%, p < 0.05). Markers of thromboinflammation were also quantified in two patients admitted to the hospital with sickle cell disease (SCD) crisis. Both SCD patients had pronounced hemolysis and depleted plasma hemopexin and haptoglobin. Plasma heme and complement activation was markedly increased in one patient, a coinciding observation as demonstrated ex vivo. In conclusion, heme-induced thromboinflammation was largely attenuated by C5 inhibition alone, with a beneficial effect of adding a CD14 inhibitor to attenuate prothrombin activation. Targeting C5 has the potential to reduce thromboinflammation in SCD crisis patients.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Gerogianni, AlexandraLinnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Linnaeus Ctr Biomat Chem, BMC;HoRB(Swepub:lnu)algeab (author)
  • McAdam, Martin B.Oslo Univ Hosp, Norway;Univ Oslo, Norway (author)
  • Floisand, YngvarOslo Univ Hosp, Norway (author)
  • Lau, CorinnaNordland Hosp, Norway (author)
  • Espevik, TerjeNorwegian Univ Sci & Technol, Norway (author)
  • Nilsson, Per H.,1980-Linnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Avancerade material,Oslo Univ Hosp, Norway;Univ Oslo, Norway,Linnaeus Ctr Biomat Chem, BMC;HoRB(Swepub:lnu)enipe (author)
  • Mollnes, Tom EirikOslo Univ Hosp, Norway;Univ Tromso, Norway (author)
  • Barratt-Due, AndreasOslo Univ Hosp, Norway;Univ Oslo, Norway (author)
  • Oslo Univ Hosp, Norway;Univ Oslo, NorwayInstitutionen för kemi och biomedicin (KOB) (creator_code:org_t)

Related titles

  • In:Journal of Immunology: American Association for Immunologists203:6, s. 1571-15780022-17671550-6606

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view